Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The FDA has issued safety communications regarding compounded GLP-1 receptor agonists, including tirzepatide and semaglutide, warning about adverse events from bacterial contamination, incorrect dosing, and use of improper ingredients
Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will roll out a new, temporary program covering GLP-1s for obesity for people with Medicare
Novo Nordisk is acutely aware of the uncertainty and concern this is causing, and the disruption patients and healthcare professionals are experiencing
Can I switch from semaglutide to tirzepatide (or vice versa)
And then the next week they're publishing something of like, Oh, you're all being, you know, crazy on this, like Ozempic craze and you're killing yourself
